Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Update

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 600 shares, a growth of 20.0% from the October 31st total of 500 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 1.5 days.

Mosaic ImmunoEngineering Stock Performance

CPMV opened at $1.00 on Tuesday. The stock has a market capitalization of $7.24 million, a P/E ratio of -6.67 and a beta of 0.01. Mosaic ImmunoEngineering has a 12 month low of $0.10 and a 12 month high of $1.13. The firm’s fifty day simple moving average is $0.91 and its 200 day simple moving average is $0.77.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.